172 related articles for article (PubMed ID: 23954084)
1. Hybrid positron emission tomography-magnetic resonance imaging with gallium 68 prostate-specific membrane antigen tracer: a next step for imaging of recurrent prostate cancer-preliminary results.
Roethke MC; Kuru TH; Afshar-Oromieh A; Schlemmer HP; Hadaschik BA; Fenchel M
Eur Urol; 2013 Nov; 64(5):862-4. PubMed ID: 23954084
[No Abstract] [Full Text] [Related]
2. Whole-Body Integrated [
Guberina N; Hetkamp P; Ruebben H; Fendler W; Grueneisen J; Suntharalingam S; Kirchner J; Puellen L; Harke N; Radtke JP; Umutlu L; Hadaschik BA; Herrmann K; Forsting M; Wetter A
Mol Imaging Biol; 2020 Jun; 22(3):788-796. PubMed ID: 31482413
[TBL] [Abstract][Full Text] [Related]
3. Reply to Reske et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.
Afshar-Oromieh A; Malcher A; Eder M; Eisenhut M; Linhart HG; Hadaschik BA; Holland-Letz T; Giesel FL; Kratochwil C; Haufe S; Haberkorn U; Zechmann CM
Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):971-2. PubMed ID: 23558688
[No Abstract] [Full Text] [Related]
4. Comment on Afshar-Oromieh et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.
Reske SN; Winter G; Baur B; Machulla HJ; Kull T
Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):969-70. PubMed ID: 23558687
[No Abstract] [Full Text] [Related]
5. PSMA Theranostics Using PET and Subsequent Radioguided Surgery in Recurrent Prostate Cancer.
Maurer T; Schwamborn K; Schottelius M; Wester HJ; Schwaiger M; Gschwend JE; Eiber M
Clin Genitourin Cancer; 2016 Oct; 14(5):e549-e552. PubMed ID: 27318956
[No Abstract] [Full Text] [Related]
6. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.
Perera M; Papa N; Roberts M; Williams M; Udovicich C; Vela I; Christidis D; Bolton D; Hofman MS; Lawrentschuk N; Murphy DG
Eur Urol; 2020 Apr; 77(4):403-417. PubMed ID: 30773328
[TBL] [Abstract][Full Text] [Related]
7. [PSMA-radioguided surgery in localised recurrent prostate cancer].
Horn T; Rauscher I; Eiber M; Gschwend JE; Maurer T
Urologe A; 2017 Nov; 56(11):1417-1423. PubMed ID: 29022058
[TBL] [Abstract][Full Text] [Related]
8. [Ga-68-PSMA PET/CT for prostate cancer].
Hellwig D; Moosbauer J; Eilles C
Aktuelle Urol; 2014 Nov; 45(6):457-63. PubMed ID: 25518963
[TBL] [Abstract][Full Text] [Related]
9. Clinical performance of
Kranzbühler B; Nagel H; Becker AS; Müller J; Huellner M; Stolzmann P; Muehlematter U; Guckenberger M; Kaufmann PA; Eberli D; Burger IA
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):20-30. PubMed ID: 29032394
[TBL] [Abstract][Full Text] [Related]
10. (68)Ga-PSMA PET/MR with multimodality image analysis for primary prostate cancer.
Eiber M; Nekolla SG; Maurer T; Weirich G; Wester HJ; Schwaiger M
Abdom Imaging; 2015 Aug; 40(6):1769-71. PubMed ID: 25412869
[TBL] [Abstract][Full Text] [Related]
11. Integrated
Lütje S; Cohnen J; Gomez B; Grüneisen J; Sawicki L; Rübben H; Bockisch A; Umutlu L; Pöppel TD; Wetter A
Nuklearmedizin; 2017 Jun; 56(3):73-81. PubMed ID: 28401244
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with
Ferraro DA; Rüschoff JH; Muehlematter UJ; Kranzbühler B; Müller J; Messerli M; Husmann L; Hermanns T; Eberli D; Rupp NJ; Burger IA
Theranostics; 2020; 10(14):6082-6094. PubMed ID: 32483440
[TBL] [Abstract][Full Text] [Related]
13. Intense PSMA-expression using (68)Ga-PSMA PET/CT in a paravertebral schwannoma mimicking prostate cancer metastasis.
Rischpler C; Maurer T; Schwaiger M; Eiber M
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):193-194. PubMed ID: 26502982
[No Abstract] [Full Text] [Related]
14.
Farolfi A; Gafita A; Calais J; Eiber M; Afshar-Oromieh A; Spohn F; Barbato F; Weber M; Ilhan H; Cervati V; Wetter A; Hadaschik B; Briganti A; Walz J; Pianori D; Fanti S; Haberkorn U; Herrmann K; Fendler WP
J Urol; 2019 Dec; 202(6):1174-1181. PubMed ID: 31233369
[TBL] [Abstract][Full Text] [Related]
15. [PSMA-PET/CT has to be performed in every patient with biochemical recurrence following radical prostatectomy for early tumor detection].
Kotzerke J; Böhmer D; Schlomm T; Maurer T; Beer AJ; Schmidberger H
Nuklearmedizin; 2018 Jun; 57(3):69-73. PubMed ID: 29871008
[TBL] [Abstract][Full Text] [Related]
16. [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH.
Afshar-Oromieh A; Haberkorn U; Eder M; Eisenhut M; Zechmann CM
Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):1085-6. PubMed ID: 22310854
[No Abstract] [Full Text] [Related]
17. PET/MRI with a 68Ga-PSMA ligand for the detection of prostate cancer.
Afshar-Oromieh A; Haberkorn U; Hadaschik B; Habl G; Eder M; Eisenhut M; Schlemmer HP; Roethke MC
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1629-30. PubMed ID: 23817686
[No Abstract] [Full Text] [Related]
18.
von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.
Jilg CA; Drendel V; Rischke HC; Beck T; Vach W; Schaal K; Wetterauer U; Schultze-Seemann W; Meyer PT
Theranostics; 2017; 7(6):1770-1780. PubMed ID: 28529650
[No Abstract] [Full Text] [Related]
20. The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.
Afshar-Oromieh A; Avtzi E; Giesel FL; Holland-Letz T; Linhart HG; Eder M; Eisenhut M; Boxler S; Hadaschik BA; Kratochwil C; Weichert W; Kopka K; Debus J; Haberkorn U
Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):197-209. PubMed ID: 25411132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]